Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses

The ability to predict responsiveness to drugs in individual patients is limited. We hypothesized that integrating molecular information from databases would yield predictions that could be experimentally tested to develop transcriptomic signatures for specific drugs. We analyzed lung adenocarcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavassoly, Iman, Hu, Yuan, Zhao, Shan, Mariottini, Chiara, Boran, Aislyn, Chen, Yibang, Li, Lisa, Tolentino, Rosa E., Jayaraman, Gomathi, Goldfarb, Joseph, Gallo, James, Iyengar, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670022/
https://www.ncbi.nlm.nih.gov/pubmed/31116490
http://dx.doi.org/10.1002/1878-0261.12521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670022/
https://www.ncbi.nlm.nih.gov/pubmed/31116490
http://dx.doi.org/10.1002/1878-0261.12521

Ejemplares similares